Funder
MIUR-SIR projects
Oxalosis and Hyperoxaluria Foundation
Publisher
Springer Science and Business Media LLC
Reference115 articles.
1. Alagia A, Eritja R (2016) siRNA and RNAi optimization Wiley. Interdiscip Rev RNA 7:316–329.
https://doi.org/10.1002/wrna.1337
2. Alegra T, Vairo F, de Souza MV, Krug BC, Schwartz IV (2012) Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis. Genet Mol Biol 35:947–954
3. Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7
4. Andy V, Horvath P, Wanders RJ (1995) Aminooxy acetic acid: a selective inhibitor of alanine:glyoxylate aminotransferase and its use in the diagnosis of primary hyperoxaluria type I Clinica chimica acta. Int J Clin Chem 243:105–114
5. Arvans D et al (2017) Oxalobacter formigenes-derived bioactive factors stimulate oxalate transport by intestinal epithelial cells. J Am Soc Nephrol JASN 28:876–887.
https://doi.org/10.1681/ASN.2016020132
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献